Search Results for: ARCA Biopharma Announces Completion of
Articles
December 2, 2021
ARCA biopharma Announces Completion of Enrollment in Phase 2b ASPEN-COVID-19 Clinical Trial Evaluating rNAPc2 as a Potential Treatment for Patients Hospitalized With COVID-19 December 2, 2021
ARCA biopharma, Inc. recently announced that enrollment has been completed in ASPEN-COVID-19, the Phase 2b clinical trial evaluating rNAPc2 as a...
January 16, 2018
ARCA Biopharma Announces Completion of GENETIC-AF Phase 2B Clinical Trial January 16, 2018
ARCA Biopharma, Inc. recently announced the completion of patient follow-up for GENETIC-AF, a Phase 2B, double-blind, superiority clinical trial evaluating...
June 6, 2023
Anavex Life Sciences Announces Completion of Phase 2/3 Rett Syndrome Clinical Trial June 6, 2023
Anavex Life Sciences Corp. recently announced the completion of dosing of all participants of the placebo-controlled EXCELLENCE Phase 2/3 study...
December 11, 2018
Kiniksa Announces Rilonacept Interim Phase 2 Clinical Data; Initiates Pivotal Phase 3 Clinical Trial December 11, 2018
Kiniksa Pharmaceuticals, Ltd.recently announced interim data from an open-label Phase 2 clinical trial of rilonacept, a weekly, subcutaneously-injected, recombinant fusion...
June 23, 2017
ARCA Biopharma Announces Database Lock for GENETIC-AF Phase 2B Interim Efficacy Analysis June 23, 2017
ARCA biopharma, Inc. recently announced database lock for the GENETIC-AF Phase 2B interim efficacy analysis, to be conducted by the...
